Kronos Bio Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KRON is expected to report earnings to fall 30.23% to -30 cents per share on May 07
Q1'25
Est.
$-0.30
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
The last earnings report on March 18 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 11.03K shares outstanding, the current market capitalization sits at 54.14M.